Last reviewed · How we verify

NCT05657886

Half Swaddle and Kangaroo Care in Preterm on Breastfeeding, Infant Attachment, Sleep Quality and Depression of Mothers

Completed NA Last updated 22 December 2022
What this trial tests

NA trial testing Half swaddle in Kangaroo Care in 160 participants. Completed in 2 March 2022.

Timeline
5 July 2020
Primary endpoint
5 January 2021
2 March 2022

Quick facts

Lead sponsorTrakya University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment160
Start date5 July 2020
Primary completion5 January 2021
Estimated completion2 March 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Trakya University

Who can join

Adults 18 to 49, female only, with Kangaroo Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: The aim of this study is to investigate the effect of half swaddle and kangaroo care practices initiated in the early period in preterm infants on breastfeeding, mother-infant attachment, maternal sleep quality and postpartum depression. Design: The prospective, randomized controlled study

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Breastfeeding interventions for preventing postpartum depression.
    Lenells M, Uphoff E, Marshall D, Wilson E, et al · · 2025 · cited 1× · PMID 39963955 · DOI 10.1002/14651858.cd014833.pub2

Verify or expand the search:

Other trials of Half swaddle

Trials testing the same drug.

Other recruiting trials for Kangaroo Care

Currently open trials in the same condition.

Other Trakya University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05657886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing